Celsius Holdings Inc. (NASDAQ:CELH – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-two research firms that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation and nineteen have given a buy recommendation to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $62.40.
A number of brokerages have commented on CELH. B. Riley upped their target price on shares of Celsius from $56.00 to $75.00 and gave the company a “buy” rating in a report on Tuesday, September 2nd. Citigroup reissued a “buy” rating on shares of Celsius in a research report on Sunday, August 31st. Roth Capital raised their target price on Celsius from $58.00 to $70.00 and gave the stock a “buy” rating in a report on Tuesday, September 2nd. Cowen reiterated a “buy” rating on shares of Celsius in a research report on Tuesday, September 2nd. Finally, TD Cowen upgraded Celsius from a “hold” rating to a “buy” rating and upped their price target for the stock from $37.00 to $55.00 in a research report on Monday, June 16th.
Get Our Latest Stock Analysis on CELH
Celsius Trading Up 1.0%
Celsius (NASDAQ:CELH – Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.47 EPS for the quarter, beating the consensus estimate of $0.23 by $0.24. Celsius had a net margin of 7.91% and a return on equity of 36.88%. The firm had revenue of $739.30 million during the quarter, compared to analyst estimates of $632.13 million. During the same quarter in the prior year, the firm earned $0.28 EPS. The business’s revenue for the quarter was up 83.9% compared to the same quarter last year. Analysts expect that Celsius will post 0.89 EPS for the current year.
Insider Activity at Celsius
In related news, major shareholder William H. Milmoe sold 100,000 shares of the company’s stock in a transaction on Thursday, July 31st. The shares were sold at an average price of $47.50, for a total value of $4,750,000.00. Following the completion of the transaction, the insider owned 17,717,770 shares of the company’s stock, valued at approximately $841,594,075. This represents a 0.56% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Paul H. Storey sold 7,500 shares of the company’s stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $60.93, for a total value of $456,975.00. Following the completion of the transaction, the insider directly owned 37,550 shares of the company’s stock, valued at approximately $2,287,921.50. This trade represents a 16.65% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 560,667 shares of company stock worth $27,240,162 in the last 90 days. Insiders own 2.20% of the company’s stock.
Hedge Funds Weigh In On Celsius
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. ProShare Advisors LLC boosted its stake in Celsius by 3.9% during the second quarter. ProShare Advisors LLC now owns 6,970 shares of the company’s stock valued at $323,000 after buying an additional 261 shares during the last quarter. Blue Chip Partners LLC increased its stake in Celsius by 2.4% during the second quarter. Blue Chip Partners LLC now owns 11,701 shares of the company’s stock worth $543,000 after acquiring an additional 271 shares during the last quarter. Quadrant Capital Group LLC increased its stake in Celsius by 1.6% during the second quarter. Quadrant Capital Group LLC now owns 18,221 shares of the company’s stock worth $845,000 after acquiring an additional 279 shares during the last quarter. Spire Wealth Management raised its position in Celsius by 12.0% during the first quarter. Spire Wealth Management now owns 2,677 shares of the company’s stock valued at $95,000 after purchasing an additional 287 shares during the period. Finally, Wealthcare Advisory Partners LLC lifted its stake in shares of Celsius by 3.2% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 9,718 shares of the company’s stock valued at $346,000 after purchasing an additional 301 shares during the last quarter. Institutional investors own 60.95% of the company’s stock.
About Celsius
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Further Reading
- Five stocks we like better than Celsius
- Buy P&G Now, Before It Sets A New All-Time High
- PayPal Stock: Why Wall Street May Be Undervaluing This Giant
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Why Vertical Aerospace Could Lead the eVTOL Market by 2028
- Stock Market Sectors: What Are They and How Many Are There?
- Is Draganfly’s Army Partnership a Game-Changer for Investors?
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.